Abstract
摘要
相似文献
1
Simvastatin.
Aust Nurses J. 1991 Jul;21(1):29-30.
2
[Simvastatin in the treatment of hypercholesterolemia].[辛伐他汀治疗高胆固醇血症]
Clin Ter. 1991 Jun 15;137(5):333-7.
3
Worldwide experience with simvastatin/lovastatin.
Eur Heart J. 1992 Jul;13 Suppl B:21-2. doi: 10.1093/eurheartj/13.suppl_b.21.
4
Long-term clinical tolerance of lovastatin and simvastatin.
Cardiology. 1990;77 Suppl 4:58-65. doi: 10.1159/000174684.
5
HMG CoA reductase inhibitors in the treatment of hypercholesterolaemias.
Q J Med. 1990 Feb;74(274):111-5.
6
HMGCoA reductase inhibitors lovastatin and simvastatin in the treatment of hypercholesterolemia after renal transplantation.HMGCoA还原酶抑制剂洛伐他汀和辛伐他汀在肾移植术后高胆固醇血症治疗中的应用。
Transplant Proc. 1993 Feb;25(1 Pt 2):1043-6.
7
Marked improvement in cholestasis and hypercholesterolemia with simvastatin in a patient with primary biliary cirrhosis.辛伐他汀治疗原发性胆汁性肝硬化患者的胆汁淤积和高胆固醇血症效果显著。
Am J Gastroenterol. 1995 Jul;90(7):1187-8.
8
Reductase inhibitor therapy of hypercholesterolemia.高胆固醇血症的还原酶抑制剂疗法。
Trans Am Clin Climatol Assoc. 1991;102:153-63; discussion 163-5.
9
[Swiss simvastatin multicenter study: 1. Efficacy of 10 mg simvastatin daily in patients with primary hypercholesterolemia].[瑞士辛伐他汀多中心研究：1. 每日10毫克辛伐他汀对原发性高胆固醇血症患者的疗效]
Schweiz Med Wochenschr. 1989 Dec 2;119(48):1719-23.
10
An overview: long-term tolerability of lovastatin and simvastatin.
Zhonghua Yi Xue Za Zhi (Taipei). 1992 Feb;49(2):138-9.
引用本文的文献
1
Testing of drugs using human feto-maternal interface organ-on-chips provide insights into pharmacokinetics and efficacy.利用人胎-母体界面器官芯片对药物进行测试可深入了解药物的药代动力学和疗效。
Lab Chip. 2022 Nov 22;22(23):4574-4592. doi: 10.1039/d2lc00691j.
Zotero 插件